JTO Clinical and Research Reports
Ultrarapid EGFR Mutation Screening Followed by Comprehensive NextGeneration
Home Page: JTO Clinical and Research Reports
JTO & JTO CRR (@JTOonline) / Twitter
JTO Clinical and Research Reports | Journal | ScienceDirect.com by Elsevier
Ultrarapid EGFR Mutation Screening Followed by Comprehensive NextGeneration
Home Page: JTO Clinical and Research Reports
Home Page: JTO Clinical and Research Reports
JTO & JTO CRR on Twitter: "Our Editor-in-Chief, Dr. Alex Adjei, addresses the @IASLC #WCLC19 General Assembly, describing the incredible growth of the JTO (including a new impact factor of 12.460) and
Journals | IASLC
Archive of "JTO Clinical and Research Reports". - PMC
Home Page: JTO Clinical and Research Reports
Journal of Clinical Research and Reports| Auctores
Journals | IASLC
Journal of Thoracic Oncology | Elsevier Pharma Solutions
Impact of Joint Lung Cancer Screening and Cessation Interventions Under the New Recommendations of the U.S. Preventive Services Task Force - Journal of Thoracic Oncology
Ultrarapid EGFR Mutation Screening Followed by Comprehensive NextGeneration
Home Page: JTO Clinical and Research Reports
Subscribe to Journal of Thoracic Oncology - 1556-0864
JTO & JTO CRR (@JTOonline) / Twitter
PDF) A Systematic Review and Meta-analysis of Clinical Characteristics and Outcomes in Lung Cancer Patients with COVID-19
Real-World Scenario of Patients With Lung Cancer Amid the Coronavirus Disease 2019 Pandemic in the People's Republic of China - ScienceDirect
Real-World Scenario of Patients With Lung Cancer Amid the Coronavirus Disease 2019 Pandemic in the People's Republic of China - ScienceDirect
Updated Efficacy Analysis Including Secondary Population Results for OAK: A Randomized Phase III Study of Atezolizumab versus Docetaxel in Patients with Previously Treated Advanced Non–Small Cell Lung Cancer - Journal of Thoracic
JTO & JTO CRR on Twitter: "Our Editor-in-Chief, Dr. Alex Adjei, addresses the @IASLC #WCLC19 General Assembly, describing the incredible growth of the JTO (including a new impact factor of 12.460) and
Real-World Scenario of Patients With Lung Cancer Amid the Coronavirus Disease 2019 Pandemic in the People's Republic of China - ScienceDirect
